Zone 1 Endovascular Balloon Occlusion of the Aorta vs Resuscitative Thoracotomy for Patient Resuscitation After Severe Hemorrhagic Shock
JAMA Surgery · 2023
DOI: 10.1001/jamasurg.2022.6393 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Surgery, 2023. Verfasst von Alexis L Cralley und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, University of Colorado, Denver. Hauptthemen laut MEDLINE: Shock, Hemorrhagic, Cardiopulmonary Resuscitation, Aortic Diseases, Balloon Occlusion. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Themen: Reanimation
Abstract (Originalsprache)
Importance Aortic occlusion (AO) is a lifesaving therapy for the treatment of severe traumatic hemorrhagic shock; however, there remains controversy whether AO should be accomplished via resuscitative thoracotomy (RT) or via endovascular balloon occlusion of the aorta (REBOA) in zone 1.
Objective
To compare outcomes of AO via RT vs REBOA zone 1. Design, Setting, and Participants This was a comparative effectiveness research study using a multicenter registry of postinjury AO from October 2013 to September 2021. AO via REBOA zone 1 (above celiac artery) was compared with RT performed in the emergency department of facilities experienced in both procedures and documented in the prospective multicenter Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) registry. Propensity score matching (PSM) with exact institution matching was used, in addition to subgroup multivariate analysis to control for confounders. The study setting included the ED, where AO via RT or REBOA was performed, and participants were adult trauma patients 16 years or older. Exposures AO via REBOA zone 1 vs RT. Main Outcomes and Measures The primary outcome was survival. Secondary outcomes were ventilation-free days (VFDs), intensive care unit (ICU)–free days, discharge Glasgow Coma Scale score, and Glasgow Outcome Score (GOS).
Results
A total of 991 patients (median [IQR] age, 32 [25-48] years; 808 male individuals [81.9%]) with a median (IQR) Injury Severity Score of 29 (18-50) were included. Of the total participants, 306 (30.9%) had AO via REBOA zone 1, and 685 (69.1%) had AO via RT. PSM selected 112 comparable patients (56 pairs). REBOA zone 1 was associated with a statistically significant lower mortality compared with RT (78.6% [44] vs 92.9% [52]; P = .03). There were no significant differences in VFD greater than 0 (REBOA, 18.5% [10] vs RT, 7.1% [4]; P = .07), ICU-free days greater than 0 (REBOA, 18.2% [10] vs RT, 7.1% [4]; P = .08), or discharge GOS of 5 or more (REBOA, 7.5% [4] vs RT, 3.6% [2]; P = .38). Multivariate analysis confirmed the survival benefit of REBOA zone 1 after adjustment for significant confounders (relative risk [RR], 1.25; 95% CI, 1.15-1.36). In all subgroup analyses (cardiopulmonary resuscitation on arrival, traumatic brain injury, chest injury, pelvic injury, blunt/penetrating mechanism, systolic blood pressure ≤60 mm Hg on AO initiation), REBOA zone 1 offered an either similar or superior survival. Conclusions and Relevance Results of this comparative effectiveness research suggest that REBOA zone 1 provided better or similar survival than RT for patients requiring AO postinjury. These findings provide the ethically necessary equipoise between these therapeutic approaches to allow the planning of a randomized controlled trial to establish the safety and effectiveness of REBOA zone 1 for AO in trauma resuscitation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, School of Medicine, University of Colorado, Denver.
- Ernest E. Moore Shock Trauma Center at Denver Health, Denver, Colorado.
- Department of Surgery, School of Medicine, University of Texas, Austin.
- Department of Surgery, University of California, Riverside School of Medicine, Moreno Valley.
- Department of Health Systems, Management and Policy, School of Public Health, University of Colorado Denver, Aurora.
Förderung
- NIGMS NIH HHS
Zitieren
APA
Cralley, A. L., Vigneshwar, N., Moore, E. E., Dubose, J., Brenner, M. L., Sauaia, A., & AAST AORTA Study Group (2023). Zone 1 Endovascular Balloon Occlusion of the Aorta vs Resuscitative Thoracotomy for Patient Resuscitation After Severe Hemorrhagic Shock. JAMA Surgery. https://doi.org/10.1001/jamasurg.2022.6393
Vancouver
Cralley AL, Vigneshwar N, Moore EE, Dubose J, Brenner ML, Sauaia A, et al. Zone 1 Endovascular Balloon Occlusion of the Aorta vs Resuscitative Thoracotomy for Patient Resuscitation After Severe Hemorrhagic Shock. JAMA Surgery. 2023. doi:10.1001/jamasurg.2022.6393
BibTeX
@article{Cralley2023,
author = {Cralley, Alexis L and Vigneshwar, Navin and Moore, Ernest E and Dubose, Joseph and Brenner, Megan L and Sauaia, Angela and AAST AORTA Study Group, AAST AORTA Study Group},
title = {Zone 1 Endovascular Balloon Occlusion of the Aorta vs Resuscitative Thoracotomy for Patient Resuscitation After Severe Hemorrhagic Shock},
journal = {JAMA Surgery},
year = {2023},
doi = {10.1001/jamasurg.2022.6393}
}
EUVIMED